Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04807660

Bacteriological Evaluation of Children With Otorrhea

Bacteriological Evaluation of Spontaneous Otorrhea in Children

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,500 (estimated)
Sponsor
Association Clinique Thérapeutique Infantile du val de Marne · Academic / Other
Sex
All
Age
3 Months – 15 Years
Healthy volunteers
Not accepted

Summary

After pneumococcal conjugate vaccine implementation, the number of acute otitis media (AOM) episodes has decreased, but AOM still remains among the most common diagnoses in childhood. From 2% to 17% of cases of AOM feature spontaneous perforation of the tympanic membrane (SPTM). The aim of this study was to describe the bacteriological causes of SPTM several years after PCV13 implementation, in 2010.

Detailed description

Since October 2015, children with spontaneous perforation of the tympanic membrane (SPTM) are prospectively enrolled by 20 pediatricians who are part of a research and teaching network (ACTIV, Association Clinique et Thérapeutique Infantile du Val de Marne \[Clinical and Therapeutic Association of Val de Marne\]) throughout France. For some patients, otorrhea is the first manifestation of AOM; for others, otorrhea occurred after AOM treatment failure or recurrence. Failure (non-responsive AOM) is defined as otorrhea appearing despite at least 48 hr of antibiotics or recurring less than 4 days after the end of antibiotic treatment. Recurrence is defined by the appearance of otorrhea 4 to 30 days after the end of antibiotic treatment for AOM. Middle ear fluid (MEF) is obtained by sampling spontaneous discharge according to clinical practice guidelines. MEF specimens are obtained with cotton-tipped wire swabs, immediately placed in transport medium (Copan Venturi Transystem®, Brescia, Italy), and transported within 48 hr to one of the two centralized microbiology laboratories (Robert Debré Hospital or National Centre for Pneumococci at European Georges Pompidou Hospital, Paris, France).

Conditions

Interventions

TypeNameDescription
OTHERmiddle ear fluid sample for bacterial analysis (conventional microbiology analysis)A middle ear fluid sample will be collected from each enrolled child for the third analysis procedure.

Timeline

Start date
2015-10-01
Primary completion
2028-10-31
Completion
2028-10-31
First posted
2021-03-19
Last updated
2026-03-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04807660. Inclusion in this directory is not an endorsement.

Bacteriological Evaluation of Children With Otorrhea (NCT04807660) · Clinical Trials Directory